Company profile

Aurinia Pharmaceuticals Inc. Insider Trading

AUPH

Every SEC Form 4 insider trading filing for Aurinia Pharmaceuticals Inc. (AUPH) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001600620
Filings
79
Insiders
24
Last filing
2026-06-04

Activity summary

No insider transactions in the last 30 days. The most recent was on June 4, 2026, when Goetz Kathleen bought 23,931 shares. 79 filings from 24 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q2 23 to Q2 26. Aurinia Pharmaceuticals Inc. insiders are net buyers across the period shown.

Q2 23Q3 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $13.6M.

90 day insight

Over the last 90 days, Aurinia Pharmaceuticals Inc. insiders bought $12.5M across 9 transactions with no open-market sales.

  • Most active insider: Tang Kevin with 6 transactions totaling $12.5M.
  • Largest single purchase: $5.2M by Tang Kevin on Jun 1, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Goetz KathleenAUPH
Award
23,931
Jun 4, 2026Bailey Jeffrey AllenAUPH
Award
23,931
Jun 4, 2026Nova Tina SusanAUPH
Award
23,931
Jun 4, 2026Johnson Craig AAUPH
Award
23,931
Jun 2, 2026Tang KevinAUPH
J
10,000$1.65$17K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=AUPH" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Tang KevinChief Executive Officer11 filings+$25.1M
Greenleaf PeterChief Executive Officer3 filings$4.7M
Donley Matthew MaxwellEVP, Ops & Strategy3 filings$1.7M
Robertson Stephen P.Chief Legal Officer3 filings$1.7M
Miller Joseph MChief Financial Officer3 filings$1.6M

Institutional Ownership

Top 13F-HR holders of Aurinia Pharmaceuticals Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$291.0M
QoQ change
-72.3%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$88.7M
5.2M shares
#2
State Street Corp
CIK 0000093751
$43.9M
2.6M shares
#3
BlackRock, Inc.
CIK 0002012383
$27.2M
1.6M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →